Cabaletta Bio Inc (NASDAQ: CABA) Is Under Pressure Due To Weak Fundamental Momentum.


In the last trading session, 1.02 million Cabaletta Bio Inc (NASDAQ:CABA) shares changed hands as the company’s beta touched 2.41. With the company’s per share price at $16.18 changed hands at -$0.85 or -4.99% during last session, the market valuation stood at $693.31M. CABA’s last price was a discount, traded about -62.86% off its 52-week high of $26.35. The share price had its 52-week low at $7.69, which suggests the last value was 52.47% up since then. When we look at Cabaletta Bio Inc’s average trading volume, we note the 3-month average coming to 955.39K.

Cabaletta Bio Inc (NASDAQ:CABA) trade information

Instantly CABA was in red as seen at the end of in last trading. With action -10.31%, the performance over the past five days has been red. The drop to weekly highs of 19.04 subtracted -4.99% to the stock’s daily price. The company’s shares are showing year-to-date downside of -28.72%, with the 5-day performance at -10.31% in the red. However, in the 30-day time frame, Cabaletta Bio Inc (NASDAQ:CABA) is -14.66% down.

Cabaletta Bio Inc (CABA) estimates and forecasts

Data shows that the Cabaletta Bio Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 7.79% over the past 6 months, a -10.30% in annual growth rate that is considerably lower than the industry average of 13.00%.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -26.63%. The 2024 estimates are for Cabaletta Bio Inc earnings to decrease by -15.09%.

CABA Dividends

Cabaletta Bio Inc is expected to release its next quarterly earnings report in May.